PF 9404

Drug Profile

PF 9404

Alternative Names: PF 9404C

Latest Information Update: 05 Oct 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Almirall-Prodesfarma
  • Class Ischaemic heart disorder therapies; Nitro compounds; Phenoxypropanolamines; Small molecules
  • Mechanism of Action Beta-adrenergic receptor antagonists; Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Angina pectoris; Hypertension

Most Recent Events

  • 05 Oct 2001 No-Development-Reported for Angina pectoris in Spain (Unknown route)
  • 05 Oct 2001 No-Development-Reported for Hypertension in Spain (Unknown route)
  • 06 Jul 2000 Preclinical development for Hypertension in Spain (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top